Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 12/20 | 0.53 |
| ▸ | IL1B | P01584 | 5/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.34 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25300053 | 1.00 | NLRP3 (0.53) | NLRP3IL1BPIK3CDKCNH2GABRA1 | |
| SCHEMBL29030493 | 0.93 | NLRP3 (0.53) | NLRP3IL1BKCNH2GABRA1GABRG2 | |
| SCHEMBL29030498 | 0.93 | NLRP3 (0.53) | NLRP3IL1BKCNH2GABRA1GABRG2 | |
| SCHEMBL30834007 | 0.90 | NLRP3 (0.62) | NLRP3IL1BKCNH2 | |
| SCHEMBL25263725 | 0.89 | NLRP3 (0.55) | NLRP3IL1BKCNH2 | |
| SCHEMBL25302189 | 0.89 | NLRP3 (0.55) | NLRP3IL1BKCNH2 | |
| SCHEMBL25256129 | 0.87 | NLRP3 (0.57) | NLRP3IL1BKCNH2 | |
| SCHEMBL25304328 | 0.87 | NLRP3 (0.57) | NLRP3IL1BKCNH2 | |
| SCHEMBL25257343 | 0.86 | IL1B (0.54) | NLRP3IL1B | |
| SCHEMBL25296235 | 0.86 | IL1B (0.54) | NLRP3IL1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023131277-A1 | NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF | 药捷安康(南京)科技股份有限公司 | 2023-07-13 | — | — | WO | disclosed |